Rok Frlan

566 total citations
35 papers, 445 citations indexed

About

Rok Frlan is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Rok Frlan has authored 35 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Organic Chemistry and 6 papers in Pharmacology. Recurrent topics in Rok Frlan's work include Chemical Synthesis and Analysis (7 papers), Microbial Natural Products and Biosynthesis (6 papers) and Biochemical and Molecular Research (5 papers). Rok Frlan is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Microbial Natural Products and Biosynthesis (6 papers) and Biochemical and Molecular Research (5 papers). Rok Frlan collaborates with scholars based in Slovenia, France and Hungary. Rok Frlan's co-authors include Stanislav Gobec, D. Kikelj, Matej Sova, Zdenko Časar, Gaj Stavber, Andreja Kovač, Slavko Pečar, Didier Blanot, Martina Hrast and Damijan Knez and has published in prestigious journals such as The Journal of Organic Chemistry, Tetrahedron and Molecules.

In The Last Decade

Rok Frlan

33 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rok Frlan Slovenia 12 200 180 43 34 34 35 445
Ahmad Perwez India 15 174 0.9× 187 1.0× 70 1.6× 22 0.6× 40 1.2× 23 465
Hanumappa Ananda India 15 396 2.0× 260 1.4× 85 2.0× 41 1.2× 21 0.6× 23 678
Antonella Pepe United States 13 228 1.1× 264 1.5× 108 2.5× 52 1.5× 28 0.8× 25 550
Kristina M. K. Kutterer Canada 9 234 1.2× 193 1.1× 55 1.3× 40 1.2× 21 0.6× 14 398
Manikandan Kadirvel United Kingdom 12 89 0.4× 220 1.2× 37 0.9× 30 0.9× 23 0.7× 21 378
Carl E. Wagner United States 14 128 0.6× 199 1.1× 30 0.7× 19 0.6× 28 0.8× 35 493
Adam Mieczkowski Poland 12 384 1.9× 297 1.6× 31 0.7× 53 1.6× 27 0.8× 45 648
Sebastian T. Le Quement Denmark 16 395 2.0× 464 2.6× 38 0.9× 27 0.8× 20 0.6× 25 636
Stephen E. Motika United States 11 284 1.4× 226 1.3× 25 0.6× 61 1.8× 67 2.0× 13 536
Baskar Nammalwar United States 15 557 2.8× 268 1.5× 23 0.5× 37 1.1× 20 0.6× 40 726

Countries citing papers authored by Rok Frlan

Since Specialization
Citations

This map shows the geographic impact of Rok Frlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rok Frlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rok Frlan more than expected).

Fields of papers citing papers by Rok Frlan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rok Frlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rok Frlan. The network helps show where Rok Frlan may publish in the future.

Co-authorship network of co-authors of Rok Frlan

This figure shows the co-authorship network connecting the top 25 collaborators of Rok Frlan. A scholar is included among the top collaborators of Rok Frlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rok Frlan. Rok Frlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hrast, Martina, Rok Frlan, Izidor Sosič, et al.. (2025). Development and evaluation of novel InhA inhibitors inspired by thiadiazole and tetrahydropyran series of inhibitors. Acta Pharmaceutica. 75(2). 185–218.
2.
Frlan, Rok, et al.. (2024). Navigating the Chemical Space of ENR Inhibitors: A Comprehensive Analysis. Antibiotics. 13(3). 252–252. 2 indexed citations
3.
Varga, Zoltán, Ferenc Papp, Éva Korpos, et al.. (2024). Identification of a Novel Structural Class of HV1 Inhibitors by Structure-Based Virtual Screening. Journal of Chemical Information and Modeling. 64(12). 4850–4862. 3 indexed citations
4.
Frlan, Rok, et al.. (2024). Using Subcritical Water to Obtain Polyphenol-Rich Extracts with Antimicrobial Properties. Antibiotics. 13(4). 334–334. 12 indexed citations
5.
Zdovc, Irena, et al.. (2023). Mur ligase F as a new target for the flavonoids quercitrin, myricetin, and (–)-epicatechin. Journal of Computer-Aided Molecular Design. 37(12). 721–733. 4 indexed citations
6.
Hrast, Martina, et al.. (2022). Discovery of a fragment hit compound targeting D-Ala:D-Ala ligase of bacterial peptidoglycan biosynthesis. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 387–397. 3 indexed citations
7.
Hrast, Martina, et al.. (2022). DNA-encoded library screening on two validated enzymes of the peptidoglycan biosynthetic pathway. Bioorganic & Medicinal Chemistry Letters. 73. 128915–128915. 5 indexed citations
8.
9.
Hrast, Martina, et al.. (2022). The Synthesis of (2R)-Aziridine-2-carboxylic Acid Containing Dipeptides. Acta chimica slovenica. 69(2). 261–270.
10.
Hrast, Martina, Rok Frlan, Damijan Knez, et al.. (2021). Mur ligases inhibitors with azastilbene scaffold: Expanding the structure–activity relationship. Bioorganic & Medicinal Chemistry Letters. 40. 127966–127966. 9 indexed citations
11.
Knez, Damijan, Martina Hrast, Rok Frlan, et al.. (2021). Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library. Bioorganic Chemistry. 119. 105581–105581. 6 indexed citations
12.
13.
Avcı, Fatma Gizem, Rok Frlan, Tihomir Tomašič, et al.. (2020). Identification of novel inhibitors of the ABC transporter BmrA. Bioorganic Chemistry. 105. 104452–104452. 4 indexed citations
14.
Pišlar, Anja, Rok Frlan, Janko Kos, et al.. (2020). Pyrimido[1,2-b]indazole derivatives: Selective inhibitors of human monoamine oxidase B with neuroprotective activity. European Journal of Medicinal Chemistry. 209. 112911–112911. 31 indexed citations
15.
Sova, Matej, Rok Frlan, Stanislav Gobec, & Zdenko Časar. (2020). Efficient and Straightforward Syntheses of Two United States Pharmacopeia Sitagliptin Impurities: 3-Desamino-2,3-dehydrositagliptin and 3-Desamino-3,4-dehydrositagliptin. ACS Omega. 5(10). 5356–5364. 5 indexed citations
16.
Skok, Žiga, Anita Rácz, Rok Frlan, et al.. (2018). Discovery of d-amino acid oxidase inhibitors based on virtual screening against the lid-open enzyme conformation. Bioorganic & Medicinal Chemistry Letters. 28(10). 1693–1698. 4 indexed citations
17.
Frlan, Rok, Bayan Al-Dabbagh, Ahmed Bouhss, et al.. (2011). Synthesis and biological evaluation of potential new inhibitors of the bacterial transferase MraY with a β-ketophosphonate structure. Organic & Biomolecular Chemistry. 9(24). 8301–8301. 11 indexed citations
18.
Frlan, Rok, Stanislav Gobec, & D. Kikelj. (2007). Synthesis of ethyl 3-(hydroxyphenoxy)benzyl butylphosphonates as potential antigen 85C inhibitors. Tetrahedron. 63(43). 10698–10708. 14 indexed citations
19.
Gobec, Stanislav & Rok Frlan. (2006). Inhibitors of Cathepsin B. Current Medicinal Chemistry. 13(19). 2309–2327. 104 indexed citations
20.
Frlan, Rok, et al.. (2005). Effect of Preparation Temperature in Solvent Evaporation Process on Eudragit RS Microsphere Properties. Chemical and Pharmaceutical Bulletin. 53(1). 143–146. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026